1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
2GAO HW.Insulin glargine combining with the oralantidiabeticdrugs treat the type 2 diabetesfj].Clinical,2009, 29: 44-45.
3Ali A. Rizvi,Robert J. Ligthelm.The Use of Premixed Insulin Analogues in the Treatment of Patients with Type 2 Diabetes Mellitus: Advantages and Limitations[J].Insulin.2007(2)
4Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women inChina[J]. New Engl J Med,2010,362(12): 1090-1101.
5Harrison LB, Adams-Huet B, Li X, et al. Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trial[J]. JInvestig Med,2014,62(4) :676-686.
6Sperling RA, Aisen PS, Beckett LA, etal. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association Workgroups on Diagnostic Guidelines for Alzheimer's Disease [J]. Alzheimers Dement,2011,7(3) :280-292.
7Pfutzner A, Schondorf T, Hanefeld M, et al. High sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone[J]. J Diabetes Sci Technol, 2010,4 (3) : 706- 716.
